Acutus Medical, Inc. (AFIB)
NASDAQ: AFIB · IEX Real-Time Price · USD
0.174
+0.011 (6.93%)
At close: Apr 18, 2024, 3:59 PM
0.180
+0.006 (3.21%)
After-hours: Apr 18, 2024, 4:16 PM EDT
Company Description
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally.
Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs.
The company was incorporated in 2011 and is headquartered in Carlsbad, California.
Acutus Medical, Inc.
Country | United States |
Founded | 2011 |
IPO Date | Aug 6, 2020 |
Industry | Medical Devices |
Sector | Healthcare |
Employees | 230 |
CEO | Takeo Mukai |
Contact Details
Address: 2210 Faraday Ave, Suite 100 Carlsbad, California 92008 United States | |
Phone | 442-232-6080 |
Website | acutusmedical.com |
Stock Details
Ticker Symbol | AFIB |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $18.00 |
CIK Code | 0001522860 |
CUSIP Number | 005111109 |
ISIN Number | US0051111096 |
Employer ID | 45-1306615 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Takeo Mukai | Chief Executive Officer and Chief Financial Officer |
Gary W. Doherty | Senior Vice President of Finance |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 4, 2024 | 144 | Filing |
Apr 1, 2024 | 10-K | Annual Report |
Apr 1, 2024 | 8-K | Current Report |
Mar 5, 2024 | 8-K | Current Report |
Feb 8, 2024 | 8-K | Current Report |
Jan 17, 2024 | 8-K | Current Report |
Jan 11, 2024 | 8-K | Current Report |
Nov 14, 2023 | 10-Q | Quarterly Report |
Nov 13, 2023 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
Nov 13, 2023 | 8-K | Current Report |